Aion Therapeutic Announces Director Resignation
Aion Therapeutic Announces Director Resignation
TORONTO, July 6, 2023 /CNW/ - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announces that effective July 5, 2023, Rosy Mondin has resigned as a director of the Company. The Company thanks Mrs. Mondin for her service as a director of the Company and wishes her all the best in her future endeavors.
多倫多，2023年7月6日/cnw/-Aion治療公司(CSE：AION)(“Aion治療“或”公司“)宣佈生效2023年7月5日，玫瑰色蒙丹已辭去董事公司董事一職。公司感謝蒙丁女士作為公司董事的一員所提供的服務，並祝願她在未來的工作中一切順利。
About Aion Therapeutic Inc.
Aion治療公司簡介
Aion Therapeutic is a forward-thinking business within the health and wellness sector with a diverse portfolio of intellectual property. With a commitment to innovation and transformative solutions, the Company is poised to drive positive change to redefine the boundaries of health and wellness.
Aion治療是健康和健康部門內的一傢俱有前瞻性的企業，擁有多樣化的知識產權組合。憑藉對創新和變革性解決方案的承諾，該公司準備推動積極的變革，重新定義健康和健康的界限。
The Canadian Securities Exchange (operated by CNSX Markets Inc.) has neither approved nor disapproved of the contents of this press release.
加拿大證券交易所(由CNSX Markets Inc.運營)既不批准也不反對本新聞稿的內容。
SOURCE AION THERAPEUTIC INC.
來源Aion Treatment Inc.
譯文內容由第三人軟體翻譯。